Targeting MYCN Upregulates L1CAM Tumor Antigen in MYCN-dysregulated Neuroblastoma to Increase CAR T Cell Efficacy.
Laura Grunewald,Lena Andersch,Konstantin Helmsauer,Silke Schwiebert,Anika Klaus,Anton G. Henssen, Teresa Straka,Marco Lodrini, Sebastian G. Wicha,Steffen Fuchs,Falk Hertwig,Frank Westermann,Alice Vitali, Carlotta Caramel,Gabriele Buechel,Martin Eilers,Kathy Astrahantseff,Angelika Eggert,Uta E. Hoepken,Johannes H. Schulte,Thomas Blankenstein,Kathleen Anders,Annette Kuenkele PHARMACOLOGICAL RESEARCH（2025）
关键词
Adoptive T cell therapy,Childhood tumor,Combination therapy,MLN8237,MYCN-driven cancer,L1CAM-CAR T cells,Drug synergism
AI 理解论文
溯源树
样例
